Straits Times Index
3,408.15 +40.25 (+1.20%) Nikkei
40,355.40 +280.71 (+0.70%) Hang Seng
17,907.46 +138.32 (+0.78%) FTSE 100
8,121.20 -45.56 (-0.56%) Bitcoin USD
61,432.05 -1,553.85 (-2.47%) CMC Crypto 200
1,323.15 -21.36 (-1.59%)
AGC Inc. (SHJ.F)
| Previous close | 30.00 |
| Open | 30.00 |
| Bid | 30.60 x 419600 |
| Ask | 31.00 x 409500 |
| Day's range | 30.00 - 30.00 |
| 52-week range | 29.80 - 36.20 |
| Volume | |
| Avg. volume | 60 |
| Market cap | 6.429B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 49.18 |
| EPS (TTM) | 0.61 |
| Earnings date | 08 May 2024 |
| Forward dividend & yield | 1.32 (4.38%) |
| Ex-dividend date | 27 Dec 2024 |
| 1y target est | N/A |
Business WireThe AGC Group Obtains Its First Cradle to Cradle Certified® for Mirox MNGE Interior Glass Products in Asia
TOKYO, May 13, 2024--AGC Glass Asia’s Mirox MNGE, a low lead mirror, is awarded with Cradle to Cradle Certified® at the Bronze level based on version 3.1.
Business WireThe AGC Group Makes Donations to Help Victims of Eastern Taiwan Earthquake
TOKYO, April 19, 2024--The AGC Group had announced that it will donate 3 million yen to help those affected by the eastern Taiwan Earthquake.
- MediaOutReach
AGC Biologics Announces Plans for New Manufacturing Site in Yokohama Japan
The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and be operational in 2026SEATTLE, USA - News Direct - 04 January 2024 - AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced plans to construct a new manufacturing facility at AGC Inc.’s Yokohama Technical Center in Japan. The new site is a part of the CDMO’s strategic growth strategy to create more high-quali
